|
West [U.S., Europe, Australia, Brazil, Turkey] |
| Back pain | Other pain | CVD | Cancer | | |
|
Durations (weeks) | | | | | Total | Percentage |
1 | | | | 1 (Kovacic 2011) | 1 | 4% |
4 | | 1 (Kuttner 2007—IBS) | | 1 (Ulger 2010) | 2 | 7% |
6 | 1 (Galantino 04) | 2 (Evans 2011—IBS, Evans 2011—rheumatoid arthritis) | | | 3 | 11% |
7 | | | | 2 (Cohen 2004, Culos-Reed 2006) | 2 | 7% |
8 | | 3 (Carson 2011—fibromyalgia, da Silva 2007—fibromyalgia, and Garfinkel 1998—carpal tunnel) | 2 (Pullen 2008, van Montfrans 1990) | 2 (Banasik 2011, Carson 2009) | 7 | 25% |
8–10 | | | 1 (Pullen 2010) | | 1 | 4% |
10 | | | 1 (Cheema 2011) | | 1 | 4% |
12 | 6 (Jacobs 04, Sherman 05, Saper 09, Cox 10, Tilbrook 11, and Sherman 11) | | | 2 (Galantino 2012, Moadal 2007) | 8 | 29% |
16 | 1 (Williams 05) | | | | 1 | 4% |
20 | | | 1 (Cade 2010) | | 1 | 4% |
24 | 1 (Williams 09) | | | | 1 | 4% |
|
Classes/week | | | | | Total | Percentage |
|
1 hour total, then at home | | 1 (Kuttner 2007—IBS) | | | 1 | 4% |
1 | 5 (Sherman 05, Saper 09, Cox 10, Tilbrook 11, andSherman 11) | 2 (Carson 2011—fibromyalgia, da Silva 2007—fibromyalgia) | 1 (van Montfrans 1990) | 4 (Carson 2009, Cohen 2004, Culos-Reed 2006, and Moadal 2007) | 12 | 43% |
2 | 4 (Galantino 04, Jacobs 04, Williams 05, Williams 09) | 3 (Evans 2011—IBS, Evans 2011—rheumatoid arthritis, and Garfinkel 1998—carpal tunnel) | 2 (Pullen 2008, Pullen 2010) | 2 (Banasik 2011, Ulger 2010) | 11 | 39% |
2-3 | | | 1 (Cade 2010) | | 1 | 4% |
3 | | | 1 (Cheema 2011) | | 1 | 4% |
7 | | | | 1 (Kovacic 2011) | 1 | 4% |
Varies | | | | 1 (Galantino 2012) | 1 | 4% |
|
Length of single class (min.)
| | | | Total | Percentage |
|
45 | | | | 1 (Kovacic 2011) | 1 | 4% |
50 | | 1 (da Silva 2007—fibromyalgia) | 1 (Cheema 2011) | | 2 | 7% |
60 | 1 (Galantino 04) | 1 (Kuttner 2007—IBS) | 3 (Cade 2010, Pullen 2010, van Montfrans 1990) | 1 (Ulger 2010) | 6 | 21% |
60–90 | | 1 (Garfinkel 1998—carpal tunnel) | | | 1 | 4% |
70 | | | 1 (Pullen 2008) | | 1 | 4% |
71 | | | | 1 (Galantino 2012) | 1 | 4% |
75 | 5 (Sherman 05, Saper 09, Cox 10, Tilbrook 11, and Sherman 11) | | | 1 (Culos-Reed 2006) | 6 | 21% |
90 | 3 (Jacobs 04, Williams 05, and Williams 09) | 2 (Evans 2011—IBS, Evans 2011—rheumatoid arthritis) | | 2 (Banasik 2011, Moadal 2007) | 7 | 25% |
120 | | 1 (Carson 2011—fibromyalgia) | | 1 (Carson 2009) | 2 | 7% |
Not stated | | | | 1 (Cohen 2004) | 1 | 4% |
|
Total hours of classes
| | | | Total | Percentage |
|
1 | | 1 (Kuttner 2007—IBS) | | | 1 | 4% |
6.67 | | 1 (da Silva 2007—fibromyalgia) | | | 1 | 4% |
7 | | | | 1 (Kovacic 2011) | 1 | 4% |
8 | | | 1 (van Montfrans 1990) | 1 (Ulger 2010) | 2 | 7% |
8.75 | | | | 1 (Culos-Reed 2006) | 1 | 4% |
12 | 1 (Galantino 04) | | | | 1 | 4% |
15 | 5 (Sherman 05, Saper 09, Cox 10, Tilbrook 11, and Sherman 11) | | | | 5 | 18% |
16 | | 1 (Carson 2011—fibromyalgia) | 1 (Pullen 2010) | 1 (Carson 2009) | 3 | 11% |
16–18 | | 1 (Garfinkel 1998—carpal tunnel) | | | 1 | 4% |
18 | | 2 (Evans 2011—IBS, Evans 2011—rheumatoid arthritis) | | 1 (Moadal 2007) | 3 | 11% |
18.67 | | | 1 (Pullen 2008) | | 1 | 4% |
21.3 | | | | 1 (Galantino 2012) | 1 | 4% |
24 | | | | 1 (Banasik 2011) | 1 | 4% |
25 | | | 1 (Cheema 2011) | | 1 | 4% |
26 | 1 (Jacobs 04) | | | | 1 | 4% |
40–60 | | | 1 (Cade 2010) | | 1 | 4% |
48 | 1 (Williams 05) | | | | 1 | 4% |
72 | 1 (Williams 09) | | | | 1 | 4% |
Not stated | | | | 1 (Cohen 2004) | 1 | 4% |
|
Home practice (any recommended)
| | | | Total | Percentage |
|
Yes | 9 (Galantino 04, Jacobs 04, Williams 05, Sherman 04, Williams 09, Saper 09, Cox 10, Tilbrook 11, and Sherman 11) | 4 (Carson 2011—fibromyalgia, Evans 2011—IBS, Evans 2011—rheumatoid arthritis, and Kuttner 2007—IBS) | 3 (Cade 2010, Pullen 2010, and van Montfrans 1990) | 4 (Carson 2009, Cohen 2004, Galantino 2012, and Kovacic 2011) | 20 | 71% |
No | | 2 (da Silva 2007—fibromyalgia, Garfinkel 1998—carpal tunnel) | 2 (Cheema 2011, Pullen 2008) | 4 (Banasik 2011, Culos-Reed 2006, Moadal 2007, and Ulger 2010) | 8 | 29% |
|